Skip to Content for David Arnott Menu for David Arnott About Us Menu Research Menu Development Menu Medicines Menu Investors Menu Media Menu Careers Menu
Banner Image

David Arnott

David Arnott

David Arnott Senior Scientist: Protein Chemistry

Mentor Profile | Top Scientific Papers

Top Scientific Papers

  • Austin CD, Lawrence DA, Peden AA, Varfolomeev EE, Totpal K, De Maziere AM, Klumperman J, Arnott D, Pham V, Scheller RH, Ashkenazi A. Death-receptor activation halts clathrin-dependent endocytosis. Proc Natl Acad Sci U S A 2006 Jul 5; 103(27): 10283-8. View Abstract on PubMed

  • Pham V, Henzel WJ, Arnott D, Hymowitz S, Sandoval WN, Truong BT, Lowman H, Lill JR. De novo proteomic sequencing of a monoclonal antibody raised against OX40 ligand. Anal Biochem 2006 May 1; 352(1): 77-86. View Abstract on PubMed

  • Loyet KM, Stults JT, Arnott D. Mass spectrometric contributions to the practice of phosphorylation site mapping through 2003: a literature review. Mol Cell Proteomics 2005 Mar; 4(3): 235-45. View Abstract on PubMed

  • Dornan D, Wertz I, Shimizu H, Arnott D, Frantz GD, Dowd P, O'Rourke K, Koeppen H, Dixit VM. The ubiquitin ligase COP1 is a critical negative regulator of p53. Nature 2004 May 6; 429(6987): 86-92. View Abstract on PubMed

  • Wertz IE, O'Rourke KM, Zhang Z, Dornan D, Arnott D, Deshaies RJ, Dixit VM. Human De-etiolated-1 regulates c-Jun by assembling a CUL4A ubiquitin ligase. Science 2004 Feb 27; 303(5662): 1371-4. View Abstract on PubMed

  • Arnott D, Kishiyama A, Luis EA, Ludlum SG, Marsters JC Jr, Stults JT. Selective detection of membrane proteins without antibodies: a mass spectrometric version of the Western blot. Mol Cell Proteomics 2002 Feb; 1(2): 148-56. View Abstract on PubMed